Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEN16132 intra-articular dose-finding study in symptomatic primary knee osteoarthritis
2009-014918-99Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fasitibant in knee osteoarthritis (OA) (5 arms), sponsored by Menarini Group. Primary endpoint: Primary efficacy endpoint. Started Oct 2009; status: completed.
02
Drugs
fasitibant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-014918-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014918-99.